Overcoming the blood–brain tumor barrier for effective glioblastoma treatment

Olaf van Tellingen(The Netherlands Cancer Institute), Bahar Yetkin-Arik(Amsterdam UMC Location VUmc), Mark C. de Gooijer(The Netherlands Cancer Institute), Pieter Wesseling(Radboud University Nijmegen), Tom Würdinger(Harvard University), Helga E. de Vries(Amsterdam UMC Location VUmc)

Drug Resistance Updates

March 1, 2015

10.1016/j.drup.2015.02.002

Cited by 1,020

Abstract

Related Papers

The 2007 WHO Classification of Tumours of the Central Nervous System

David N. Louis, Hiroko Ohgaki, Otmar D. Wiestler et al.|Acta Neuropathologica|2007|4.6k

Tight junctions of the blood-brain barrier: development, composition and regulation.

Hartwig Wolburg, Andrea Lippoldt|PubMed|2002|1.1k

Mfsd2a is critical for the formation and function of the blood–brain barrier

Ayal Ben‐Zvi, Baptiste Lacoste, Esther Kur et al.|Nature|2014|1k

Glial influence on the blood brain barrier

Jorge I. Alvarez, Takahiro Katayama, Alexandre Prat|Glia|2013|534

Clinical significance of organic anion transporting polypeptides (OATPs) in drug disposition: their roles in hepatic clearance and intestinal absorption

Yoshihisa Shitara, Kazuya Maeda, Kazuaki Ikejiri et al.|Biopharmaceutics & Drug Disposition|2012|413